Head-to-head · WeighScore
Claya vs RxSaludable
The verdict
RxSaludable takes it — 63/100 to 62.8/100, but only just.
RxSaludable grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. RxSaludable is a Spanish-language GLP-1 weight-loss telehealth service (atencion en espanol) offering compounded semaglutide from $99 the first month ($179/mo after) and tirzepatide from $189 the first… Claya is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Claya | RxSaludable |
|---|---|---|
| WeighScore | 62.8/100 | 63/100 |
| Grade | C | C |
| Scorecard rank | #268 | #264 |
| Semaglutide | $299/mo (compounded) | $179/mo (compounded) |
| Tirzepatide | $299/mo (compounded) | $269/mo (compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Yes | Injection only |
Graded #268 · C
Strengths
- Two named licensed clinicians (Habashy, NMD MS and Barber, MD PhD) — rare transparency for compounded GLP-1
- Two named pharmacy partners with full addresses (RedRock, UT and Healthware, KY)
- Both injectable and oral-tablet forms offered for semaglutide and tirzepatide
- Weight-loss money-back guarantee published on the homepage
- Free expedited shipping included in the monthly price
Where it loses points
- States-served list not disclosed — you must check at checkout
- LegitScript certification status not displayed
- Corporate legal entity not disclosed on the site or privacy policy
- Oral compounded tablets have weaker efficacy data than injectable semaglutide
- Intro pricing is higher at refill ($299), erasing the first-month advantage
Graded #264 · C
Strengths
- Spanish-language platform with Spanish-speaking, U.S.-licensed providers — a genuine gap in GLP-1 telehealth
- Compounded semaglutide $99 first month ($179/mo after) and tirzepatide $189 first month; same price at every dose, no membership fee
- LegitScript-certified (#50274281); free expedited shipping; named obesity-medicine physicians
- Same-day doctor visits, 24/7 support, FSA/HSA eligible, cancel anytime
Where it loses points
- Ongoing prices ($179-289/mo) are mid-range once the first-month intro ends
- Doesn't name its compounding pharmacy partners (generic 'certified pharmacies')
- No legal entity name or explicit state-coverage list published on the site
- Compounded GLP-1s are not FDA-approved (the site discloses this)
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.